Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention

Anil Desphande(University of Alabama at Birmingham), Donald D. Muccio(World Vision), Craig D. Smith(University of Dundee), LeeAnn J. Boerma(Laboratory of Molecular Genetics), Venkatram R. Atigadda(University of Alabama at Birmingham), Konstantin Christov(University of Illinois Chicago), Clinton J. Grubbs(University of Alabama at Birmingham), Kimberly K. Vines(University of Alabama at Birmingham), Fariba Moeinpour(University of Alabama at Birmingham), Susan M. Lobo-Ruppert(University of Alabama at Birmingham), Wayne J. Brouillette(University of Alabama at Birmingham), Gang Xia(World Vision)
Bioorganic & Medicinal Chemistry
December 1, 2013
Cited by 22


Related Papers